Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates

Toxicology

Volumn 197, Issue 3, 2004, Pages 189-197

  Walgren, Jennie L ^a,b   Jollow, David J ^a   McMillan, JoEllyn M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b PFIZER INC   (United States)

Author keywords

Dichloroacetate; Haloacetates; Hepatotoxicity; Peroxisome proliferation; Trichloroacetate; Trichloroethylene

Indexed keywords

ACETIC ACID; DICHLOROACETIC ACID; IODOACETIC ACID; PALMITOYL COENZYME A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRICHLOROACETIC ACID; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CYTOTOXICITY; HALOGENATION; LIVER CELL; MALE; METABOLISM; NONHUMAN; OXIDATION; PEROXISOME; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; WATER CONTAMINATION;

ACETATES; ALKANE 1-MONOOXYGENASE; ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; HEPATOCYTES; HYDROCARBONS, HALOGENATED; MALE; OXIDATION-REDUCTION; PALMITOYL COENZYME A; PEROXISOME PROLIFERATORS; PEROXISOMES; RATS; RATS, LONG-EVANS;

EID: 1642326899     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.01.007     Document Type: Article

References (43)

1. Anderson W.B., Board P.G., Gargano B., Anders M.W. Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking α-haloalkanoic acids. Chem. Res. Toxicol. 12:1999;1144-1149.
2. Austin E.W., Parrish J.M., Kinder D.H., Bull R.J. Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. Fundam. Appl. Toxicol. 31:1996;77-82.
3. Bocos C., Gottlicher M., Gearing K., Banner C., Enmark E., Teboul M., Crickmore A., Gustafsson J.-A. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J. Ster. Biochem. Mol. Biol. 53:1995;467-473.
4. Bull R.J. Mode of action of liver tumor induction by trichloroethylene and its metabolites trichloroacetate and dichloroacetate. Environ. Health Persp. 108(Suppl. 2):2000;241-259.
5. Bull R.J., Sanchez I.M., Nelson M.A., Larson J.L., Lansing A.J. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 63:1990;341-359.
6. Cannon J.R., Eacho P.I. Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver. Biochem. J. 280:1991;387-391.
7. Crebelli R., Carere A. Genetic toxicology of 1,1,2-trichloroethylene. Mutat. Res. 221:1989;11-37.
8. DeAngelo A.B., Daniel F.B., Most B.M., Olson G.R. The carcinogenicity of dichloroacetate in the male Fischer 344 rat. Toxicology. 114:1996;207-221.
9. DeAngelo A.B., Daniel F.B., Stober J.A., Olson G.R. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16:1991;337-347.
10. Elcombe C.R. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch. Toxicol. Suppl. 8:1985;6-17.
11. Elcombe C.R., Rose M.S., Pratt I.S. Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity. Toxicol. Appl. Pharmacol. 79:1985;365-376.
12. Everhart J.L., Kurtz D.T., McMillan J.M. Dichloroacetic acid induction of peroxisome proliferation in cultured hepatocytes. J. Biochem. Mol. Toxicol. 12:1998;351-359.
13. Fahrig R., Madle S., Baumann H. Genetic toxicology of trichloroethylene (TCE). Mutat. Res. 340:1995;1-36.
14. Fox A.W., Yang X., Murli H., Lawlor T.E., Cifone M.A. Absence of mutagenic effects of sodium dichloroacetate. Fundam. Appl. Toxicol. 32:1996;87-95.
15. Goldsworthy T.L., Popp J.A. Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity. Toxicol. Appl. Pharmacol. 88:1987;225-233.
16. Green S., Wahli W. Peroxisome proliferator-activated receptors: finding the orphan a home. Mol. Cell. Endocrinol. 100:1994;149-153.
17. Gruenke L.D., Konopka K., Koop D.R., Waskell L.A. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay. J. Pharmacol. Exp. Therapeut. 246:1988;454-459.
18. Herren-Freund S.L., Pereira M.A., Khoury M.D., Olson G. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 90:1987;183-189.
19. Jacobs M.N., Dickins M., Lewis D.F. Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure. J. Ster. Biochem. Mol. Biol. 84:2003;117-132.
20. Juge-Aubry C.E., Hammar E., Siegrist K.C., Pernin A., Takeshita A., Chin W.W., Burger A.G., Meier C.A. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274:1999;10505-10510.
21. Kato-Weinstein J., Stauber A.J., Orner G.A., Thrall B.D., Bull R.J. Differential effects of dihalogenated and trihalogenated acetates in the liver of B6C3F1 mice. J. Appl. Toxicol. 21:2001;81-89.
22. Kenna J.G., Satoh H., Christ D.D., Pohl L.R. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J. Pharmacol. Exp. Ther. 245:1988;1103-1109.
23. Krasner S.W., McGuire M.J., Jacangelo J.G., Patania N.L., Reagen K.M., Ajeta E.M. The occurrence of disinfection by-products in U.S. drinking water. J. Am. Water Works Assoc. 81:1989;41-53.
24. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
25. Lazarow P.B. Assay of peroxisomal beta-oxidation of fatty acids. Meth. Enzymol. 72:1981;315-319.
26. Lazennec G., Canaple L., Saugy D., Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14:2000;1962-1975.
27. Maloney E.K., Waxman D.J. trans-Activation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161:1999;209-218.
28. Maronpot R.R., Anna C.H., Devereux T.R., Lucier G.W., Butterworth B.E., Anderson M.W. Considerations concerning the murine hepatocarcinogenicity of selected chlorinated hydrocarbons. Prog. Clin. Biol. Res. 391:1995;305-323.
29. McMillan J.M., Jollow D.J. Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicol. Appl. Pharmacol. 115:1992;234-240.
30. Nakajima T., Kamijo Y., Usuda N., Liang Y., Fukushima Y., Kametani K., Gonzalez F.J., Aoyama T. Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator- activated receptor alpha (PPARalpha). Carcinogenesis. 21:2000;677-682.
31. Parrish J.M., Austin E.W., Stevens D.K., Kinder D.H., Bull R.J. Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology. 110:1996;103-111.
32. Passilly P., Schohn H., Jannin B., Malki M.C., Boscoboinik D., Dauca M., Latruffe N. Phosphorylation of peroxisome proliferator-activated receptor α in rat Fao cells and stimulation by ciprofibrate. Biochem. Pharmacol. 58:1999;1001-1008.
33. Pereira M.A. Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam. Appl. Toxicol. 31:1996;192-199.
34. Richmond R.E., Carter J.H., Carter H.W., Daniel F.B., DeAngelo A.B. Immunohistochemical analysis of dichloroacetic acid (DCA)-induced hepatocarcinogenesis in male Fishcer (F344) rats. Cancer Lett. 92:1995;67-76.
35. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., Klenk, D.C., 1985. Measurement of protein using bicinchoninic acid [published erratum appears in Anal. Biochem. 163(1) (15 May 1987) 279]. Anal. Biochem. 150, 76-85.
36. Tong Z., Board P.G., Anders M.W. Glutathione transferase zeta catalyzes the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331:1998a;371-374.
37. Tong Z., Board P.G., Anders M.W. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other α-haloacids. Chem. Res. Toxicol. 11:1998b;1332-1338.
38. Uden P.C., Miller J.W. Chlorinated acids and chloral in drinking water. J. Am. Water Works Assoc. 75:1983;524-527.
39. Walgren J.E., Kurtz D.T., McMillan J.M. The effect of the trichloroethylene metabolites trichloroacetate and dichloroacetate on peroxisome proliferation and DNA synthesis in cultured human hepatocytes. Cell Biol. Toxicol. 16:2000a;257-273.
40. Walgren J.E., Kurtz D.T., McMillan J.M. Expression of PPARα in human hepatocytes and activation by trichloroacetate and dichloroacetate. Res. Commun. Mol. Pathol. Pharmacol. 108:2000b;116-132.
41. White I.N., De Matteis F. The role of CYP forms in the metabolism and metabolic activation of HCFCs and other halocarbons. Toxicol. Lett. 124:2001;121-128.
42. White I.N., Razvi N., Gibbs A.H., Davies A.M., Manno M., Zaccaro C., De Matteis F., Pahler A., Dekant W. Neoantigen formation and clastogenic action of HCFC-123 and perchloroethylene in human MCL-5 cells. Toxicol. Lett. 124:2001;129-138.
43. Zhou Y.-C., Waxman D.J. Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. Environ. Health Persp. 106:1998;983-988.